Endothelial PDGF-B retention is required for proper investment of pericytes in the microvessel wall

Genes and Development

Volumn 17, Issue 15, 2003, Pages 1835-1840

  Lindblom, Per ^a   Gerhardt, Holger ^a   Liebner, Stefan ^b   Abramsson, Alexandra ^a   Enge, Maria ^a   Hellström, Mats ^c   Bäckström, Gudrun ^d   Fredriksson, Simon ^e   Landegren, Ulf ^e   Nyström, Henrik C ^a   Bergström, Göran ^d   Dejana, Elisabetta ^b   Östman, Arne ^d   Lindahl, Per ^a   Betsholtz, Christer ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b FIRC INSTITUTE OF MOLECULAR ONCOLOGY   (Italy)

^c Angiogenetics Sweden AB   (Sweden)

^d LUDWIG INSTITUTE FOR CANCER RESEARCH   (Sweden)

^e UPPSALA UNIVERSITY   (Sweden)

Author keywords

Cell retention; Heparan sulphate proteoglycan; Mesangial cell; PDGF; Pericyte; Retina

Indexed keywords

PLATELET DERIVED ENDOTHELIAL CELL GROWTH FACTOR;

ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; GENE TARGETING; GLOMERULOSCLEROSIS; GLOMERULUS; MESANGIUM; MICROVASCULATURE; NONHUMAN; PERICYTE; PRIORITY JOURNAL; PROTEIN MOTIF; PROTEINURIA; RETINA DEGENERATION;

ALLELES; AMINO ACID MOTIFS; AMINO ACID SEQUENCE; ANIMALS; CELL MOVEMENT; ENDOTHELIAL GROWTH FACTORS; ENDOTHELIUM, VASCULAR; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; KIDNEY; LYMPHOKINES; MICE; MICROCIRCULATION; MICROSCOPY, FLUORESCENCE; MODELS, GENETIC; MOLECULAR SEQUENCE DATA; MUTATION; PERICYTES; PHENOTYPE; PLATELET-DERIVED GROWTH FACTOR; PROTEIN STRUCTURE, TERTIARY; PROTEINURIA; PROTO-ONCOGENE PROTEINS C-SIS; RETINA; RETINAL DEGENERATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

ANIMALIA; GLOMERULUS;

EID: 0042125242     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.266803     Document Type: Article

References (38)

1. Allavena, P., Dejana, E., Bussolino, F., Vecchi, A., and Mantovani, A. 1995. Cytokine regulation of endothelial cells. In Cytokines: A practical approach (ed. F.R. Balkwill), pp. 225-245. IRL Press, Oxford.
2. Allt, G. and Lawrenson, J.G. 2001. Pericytes: Cell biology and pathology. Cells Tissues Organs 169: 1-11.
3. Andersson, M., Ostman, A., Westermark, B., and Heldin, C.H. 1994. Characterization of the retention motif in the C-terminal part of the long splice form of platelet-derived growth factor A-chain. J. Biol. Chem. 269: 926-9330.
4. Baeg, G.H. and Perrimon, N. 2000. Functional binding of secreted molecules to heparin sulphate proteoglycans in Drosophila. Curr. Opin. Cell Biol. 12: 575-580.
5. Bussolino, F., De Rossi, M., Sica, A., Colotta, F., Wang, J.M., Bocchietto, E., Padura, I.M., Bosia, A., Dejana, E., and Mantovani, A. 1991. Murine endothelioma cell lines transformed by polyoma middle T oncogene as target for and producers of cytokines. J. Immunol. 147: 2122-2129.
6. Carmeliet, P., Ng, Y.S., Nuyens, D., Theilmeier, G., Brusselmans, K., Cornelissen, I., Ehler, E., Kakkar, V.V., Stalmans, I., Mattot, V., et al. 1999. Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188. Nat. Med. 5: 495-502.
7. Delehedde, M., Seve, M., Sergeant, N., Wartelle, I., Lyon, M., Rudland, P.S., and Fernig, D.G. 2000. Fibroblast growth factor-2 stimulation of p42/44MAPK phosphorylation and IκB degradation is regulated by heparan sulfate/heparin in rat mammary fibroblasts. J. Biol. Chem. 275:33905-33910.
8. Eming, S.A., Yarmush, M.L., Krueger, G.G., and Morgan, J.R. 1999. Regulation of the spatial organization of mesenchymal connective tissue: Effects of cell-associated versus released isoforms of platelet-derived growth factor. Am. J. Pathol. 154: 281-289.
9. Enge, M., Bjarnegåd, M., Gerhardt, H., Gustafsson, E., Kalén, M., Asker, N., Hammes, H.-P., Shani, M., Fäsler, R., and Betsholtz, C. 2002. Endothelium-specific platelet-derived growth factor-B ablation mimics diabetic retinopathy. EMBO J. 21: 4307-4316.
10. Eriksson, U. and Alitalo, K. 1999. Structure, expression, and receptor-binding properties of novel vascular endothelial growth factors. Curr. Top. Microbiol. Immunol. 237: 41-57.
11. Fredriksson, S., Gullberg, M., Jarvius, J., Olsson, C., Pietras, K., Gustafsdottir, S.M., Ötman, A., and Landegren, U. 2002. Protein detection using proximity-dependent DNA ligation assays. Nat Biotechnol. 20: 473-477.
12. Fruttiger, M. 2002. Development of the mouse retinal vasculature: Angiogenesis versus vasculogenesis. Invest. Opthalmol. Vis. Sci. 43: 522-527.
13. Gallagher, J.T. 2001. Heparan sulfate: Growth control with a restricted menu. J. Clin. Invest. 108: 357-361.
14. Gerhardt, H., Golding, M., Fruttiger, M., Ruhrberg, C., Lundkvist, A., Abramsson, A., Jeltsch, M., Mitchell, C., Alitalo, K., Shima, D., et al. 2003. VEGF guides angiogenic sprouting utilizing endothelial tip-cell filopodia. J. Cell Biol. 161: 1163-177. (Published online ahead of print June 16, 2003 as 10.1083/icb.200302047.)
15. Hammes, H-P., Lin, J., Renner, O. Shani, M., Lundqvist, A., Betsholtz, C., Brownlee, M., and Deutsch, U. 2002. Pericytes and the pathogenesis of diabetic retinopathy. Diabetes 51: 3107-3112.
16. Heldin, C.H. and Westermark, B. 1999. Mechanism of action and in vivo role of platelet-derived growth factor. Physiol. Rev. 79: 1283-1316.
17. Hellström, M., Kalén, M., Lindahl, P., Abramsson, A., and Betsholtz, C. 1999. Role of PDGF-B and PDGFR-β in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse. Development 126: 3047-3055.
18. Hellström, M., Gerhardt, H., Kalén, M., Li, X., Eriksson, U., Wolburg, H., and Betsholtz, C. 2001. Lack of pericytcs leads to endothelial hyperplasia and abnormal vascular morphogenesis. J. Cell Biol. 153: 543-553.
19. Iozzo, R.V. and San Antonio, J. D. 2001. Heparan sulfate proteoglykans: Heavy hitters in the angiogenesis arena. J. Clin. Invest. 108: 349-335.
20. Klinghoffer, R.A., Mueting-Nelsen, P.F., Faerman, A., Shani, M., and Soriano, P. 2001. The two PDGF receptors maintain conserved signaling in vivo despite divergent embryological functions. Mol. Cell 7: 343-354.
21. LaRochelle, W.J., May-Siroft, M., Robbins, K.C., and Aaronson, S.A. 1991. A novel mechanism regulating growth factor association with the cell surface: Identification of a PDGF retention domain. Genes & Dev. 5: 1191-1199.
22. Levéen, P., Pekny, M., Gebre-Medhin, S., Swolin, B., Larsson, E., and Betsholtz, C. 1994. Mice deficient for PDGF B show renal, cardiovascular, and hematological abnormalities. Genes & Dev. 8: 1875-1887.
23. Lindahl, P., Johansson, B.R., Levéen, P., and Betsholtz, C. 1997. Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. Science 277: 242-245.
24. Östman, A., Bäckström, G., Fong, N., Betsholtz, C., Wernstedt, C., Hellman, U., Westermark, B., Valenzuela, P., and Heldin, C.-H. 1989. Expression of three recombinant homodimeric isoforms of PDGF in Saccharomyces cerevisiae: Evidence for difference in receptor binding and functional activities. Growth factors 1: 271-281.
25. Östman, A., Andersson, M., Betsholtz, C., Westermark, B., and Heldin, C.-H. 1991. Identification of a cell retention signal in the B-chain of PDGF and in the long splice version of the A-chain. Cell Regul 2: 503-512.
26. Park, J.E., Keller, G.A., and Ferrara, N. 1993. The vascular endothelial growth factor (VEGF) isoforms: Differential deposition into the sub-endothelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF. Mol Biol Cell 4: 1317-1326.
27. Pellegrini, L., Burke, D.F., von Delft, F., Mulloy, B., and Blundell, T.L. 2000. Crystal structure of fibroblasts growth factor receptor ectodomain bound to ligand and heparin. Nature 407: 1029-1034.
28. Perrimon, N. and Bernfield, M. 2000. Specificities of heparan sulphate proteoglycans in developmental processes. Nature 404: 725-728.
29. Pietras, K., Östman, A., Sjöquist, M., Buchdunger, E., Reed, R. K., Heldin, C.-H., and Rubin, K. 2801. Inhibition of platelet-derived growth factor receptors reduces interstitial hypertension and increases transcapillary transport in tumors. Cancer Res. 61: 5778-5783.
30. Pietras, K., Rubin, K., Sjoblom, T., Buchdunger, E., Sjoquist, M., Heldin, C. H., and Östman, A. 2002. Inhibition of PDGF receptor signaling in tumor stroma enhances antitumor effect of chemotherapy. Cancer Res. 62: 3476-5484.
31. Raines, E.W and Ross, R. 1992. Compartmentalization of PDGF on extracellular binding sites dependent on oxen-6-encoded sequences. J. Cell Biol. 116: 533-543.
32. Ruhrberg, C., Gerhardt, H., Golding, M., Watson, R., Ioannidou, S., Fujisawa, H., Betsholtz, C., and Shima, D. 2002. Spatially restricted patterning cues provided by heparin-hinding VEGF-A control blood vessel branching morphogenesis. Genes & Dev. 16: 2684-2698.
33. Sano, H., Ueda, Y., Takakura, N., Takemura, G., Doi, T., Kataoka, H., Murayama, T., Xu, Y., Sudo, T., Nishikawa, S., et al. 2002. Blockade of platelet-derived growth factor receptor-β pathways induces apoptosis of vascular endothelial cells and disrupts glomerular capillary formation in neonatal mice. Am. J. Pathol. 161: 135-143.
34. Soriano, P. 1994. Abnormal kidney development and hematological disorders in PDGF β-receptor mutant mice. Genes & Dev. 8: 1888-1896.
35. Stalmans, I., Yin-Shan, N., Rohan, R., Fruttiger, M., Bouché, A., Ÿuce, A., Fijusawa, H., Hermans, B., Shani, M., Jansen, S., et al. 2002. Arteriolar and venolar patterning in retinas of mice selectively expressing VEGF isoforms. J. Clin. Invest. 109: 327-336.
36. Tidhar, A., Reichenstein, M., Cohen, D., Faerman, A., Copeland, N.G., Gilbert, D.J., Jenkins, N.A., and Shani, M. 2001. A novel transgenic marker for migrating limb muscle precursors and for vascular smooth muscle cells. Dev. Dyn. 220: 60-73.
37. Uemura, A., Ogawa, M., Hirashima, M., Fujiwara, T., Koyama, S., Takagi, H., Honda, Y., Wiegand, S.J., Yancopoulos, G.D., and Nishikawa, S. 2002. Recombinant angiopoietin-1 restores higher-order architecture of growing blood vessels in mice in the absence of mural cells. J Clin. Invest. 110: 1619-1628.
38. Westermark, B. and Heldin, C.-H. 1985. Similar action of platelet-derived growth factor and epidermal growth factor in the prereplicative phase of human fibroblasts suggests a common intracellular pathway. J. Cell Physiol. 124: 43-48.